Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03098277 · ClinicalTrials.gov registry record · NA
Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy
A NA study of Solid Neoplasm, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
- 3
- Study locations
NCT03098277: Completed NA study of Solid Neoplasm, sponsored by University of Southern California.
NCT03098277 is a NA study of Solid Neoplasm that has completed, run by University of Southern California. The registered enrollment target is 41 participants, below the 940-participant average among 12 other Solid Neoplasm trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03098277, a NA study of Solid Neoplasm, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial studies movement tracking devices in optimizing and monitoring physical activity in patients with solid tumors undergoing chemotherapy in a health care facility during the day without spending the night. Movement tracking devices, such as Microsoft Kinect 2 and Microsoft Band 2, may help doctors learn about the health of cancer patients.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Accelerometer
- BEHAVIORAL Telephone-Based Intervention
- OTHER Physical Activity Measurement
Study Locations (3)
California
- Los Angeles County-USC Medical Center - Los Angeles
- USC / Norris Comprehensive Cancer Center - Los Angeles
- USC Norris Oncology/Hematology-Newport Beach - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2016-05-06 |
| Est. Completion | 2019-02-06 |
| Phase | NA |
What the finished NCT03098277 record still lists
NCT03098277 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 940-participant average among 12 other Solid Neoplasm trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Solid Neoplasm appearing as the primary indexed condition, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT03098277 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03098277 about?
NCT03098277 is a clinical study titled "Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy". This clinical trial studies movement tracking devices in optimizing and monitoring physical activity in patients with solid tumors undergoing chemotherapy in a health care facility during the day without spending the night. Movement tracking devices, such as Microsoft Kinect 2 and Microsoft Band 2, ...
What is the current status of trial NCT03098277?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2016-05-06. Estimated completion is 2019-02-06.
What conditions does trial NCT03098277 study?
This clinical trial studies the following conditions: Solid Neoplasm.
What interventions are being tested in trial NCT03098277?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Accelerometer (OTHER), Telephone-Based Intervention (BEHAVIORAL), Physical Activity Measurement (OTHER).
Who is sponsoring clinical trial NCT03098277?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03098277 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03098277's enrollment target sits among peer trials
41 7th of 12 higher than 6 of 12 other Solid Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Geriatric Assessment in Predicting Chemotherapy Toxicity and Vulnerabilities in Older Patients With Cancer
ACTIVE NOT RECRUITING · NA
-
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF
RECRUITING · Phase 1
-
UWCCC Molecular Tumor Board Registry
RECRUITING
-
Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
ACTIVE NOT RECRUITING · Phase 1
-
Thermal Ablation and Spine Stereotactic Radiosurgery in Treating Patients With Spine Metastases at Risk for Compressing the Spinal Cord
ACTIVE NOT RECRUITING · Phase 2
-
Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid Tumors
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI